| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $714.7M | +22.8% |
| Cost of Revenue | $156.8M | +29.3% |
| Gross Profit | $557.9M | +21.1% |
| R&D Expense | $145.8M | +91.7% |
| SG&A Expense | $110.4M | +15.8% |
| Operating Income | $190.8M | -0.6% |
| Interest Expense | $17.5M | -26.4% |
| Pre-tax Income | $191.8M | +10.6% |
| Income Tax | $46.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $453.0M | +45.4% |
| Short-term Investments | $14.2M | -66.1% |
| Accounts Receivable | $83.0M | +12.0% |
| Inventory | $7.2M | +34.2% |
| Current Assets | $579.3M | +28.4% |
| Total Assets | $999.2M | +23.1% |
| Current Liabilities | $175.1M | +6.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $219.8M | +0.2% |
| Capital Expenditures | $1.2M | +269.6% |
| Investing Cash Flow | -$67.5M | -45.3% |
| Financing Cash Flow | -$11.0M | +89.6% |
| Free Cash Flow | $218.7M | -0.2% |
| +4.0% |
| Net Income | $145.5M | +12.9% |
| EPS (Basic) | $2.56 | +18.0% |
| EPS (Diluted) | $2.51 | +17.8% |
| Long-term Debt |
| $179.3M |
| -7.4% |
| Total Liabilities | $340.0M | -1.3% |
| Stockholders' Equity | $659.2M | +41.1% |